Dr. Yue Lu Chief Physician (Vice Dean Level)

Dr. Yue Lu

Chief Physician (Vice Dean Level)
Introduction:

• Board Member of Beijing Hematology Society

• Member of the Hematopoietic Stem Cell Transplantation Group, Chinese Society of Hematology

• Committee Member of the Hematology Professional Committee, Cross-Strait Medicine and Health Exchange Association

Specialization:

• Hematopoietic Stem Cell Transplantation

• Treatment of Hematological Disorders

Biography

• 2016: Completed clinical training at Fred Hutchinson Cancer Research Center, Seattle, USA.

• Over 1,800 allogeneic stem cell transplants performed by the end of 2024.

• Published over 10 SCI papers in journals like Frontiers in Immunology, British Journal of Haematology, Bone Marrow Transplantation, etc.

Professional Experience

• 2004: Graduated from Xiangya Hospital, Central South University.

• 2004 - Present: Expert and Chief Physician at Ludaopei Medical Group, Beijing.

• 2016: Short-term clinical training at Fred Hutchinson Cancer Research Center, USA.

Academic and Clinical Contributions

Dr. Lu has contributed extensively to the global hematology community, presenting research at major international conferences, including the European Hematology Association (EHA) and American Society of Hematology (ASH) annual meetings.

Selected Research Papers

1. Yue Lu et al. "Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable with Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia." Biol Blood Marrow Transplant, 2018.

2. Yue Lu et al. "The Impact of NCCN Risk Stratification on Prognosis in Acute Myeloid Leukemia Post-Allogeneic Stem Cell Transplant." Chinese Journal of Hematology, 2017.

Additional Academic Contributions:

• Contributed to the updated edition of "Leukemia Therapy" by Academician Ludaopei, writing the chapter on allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes.

Summary:

Dr. Yue Lu is an expert in hematopoietic stem cell transplantation with over 1,800 cases performed. He is highly regarded for his research and contributions to the treatment of hematological disorders, especially in the context of transplantation. His work is internationally recognized, and he frequently contributes to major hematology conferences.